AGP Executive Report
Last update: 12 hours agoMedical Cannabis Policy: South Dakota lawmakers heard the state’s medical marijuana program is expanding fast, with home cultivation licenses jumping from 61 (FY2022) to 715 (FY2026)—a 1,072% surge—prompting calls for tighter rules and clearer inspections. Legal/Regulatory Fight: A hemp company is pushing back against a DEA position that synthetic HHC is federally illegal, arguing the agency’s “technical change” undermines its stance in ongoing court challenges. Clinical Research (HIV + Cannabis): A study of adults aging with HIV found cannabis use was linked to higher fall risk at first, but the association faded after accounting for other substances, meds, alcohol use, and smoking—still a reminder to talk with clinicians. Public Health: CDC reports predicted U.S. overdose deaths fell 12.3% for the 12 months ending March 2026, with fentanyl and stimulants driving many deaths. Safety/Access: Georgia regulators propose rules to let state-licensed medical marijuana be delivered directly to patients, potentially via USPS and major carriers, tied to federal rescheduling.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
